Deregulation of IRE1 signaling, including overactivation of XBP1 splicing, has been reported as promoting proliferation of several cancer types, including glioblastoma, breast, prostate, and pancreas (Sheng et al. 2019; Chen et al. 2014; Pommier et al. 2018). This evidence concerns the gene XBP1 and cancer.